- Home
- BKU vs IDYA Comparison
BKU vs IDYA Comparison
Compare BKU & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKU
- IDYA
- Stock Information
- Founded
- BKU 2009
- IDYA 2015
- Country
- BKU United States
- IDYA United States
- Employees
- BKU N/A
- IDYA N/A
- Industry
- BKU Savings Institutions
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- BKU Finance
- IDYA Health Care
- Exchange
- BKU Nasdaq
- IDYA Nasdaq
- Market Cap
- BKU 2.8B
- IDYA 2.3B
- IPO Year
- BKU 2011
- IDYA 2019
- Fundamental
- Price
- BKU $40.68
- IDYA $31.83
- Analyst Decision
- BKU Hold
- IDYA Buy
- Analyst Count
- BKU 12
- IDYA 14
- Target Price
- BKU $41.67
- IDYA $49.58
- AVG Volume (30 Days)
- BKU 1.1M
- IDYA 1.2M
- Earning Date
- BKU 10-22-2025
- IDYA 11-04-2025
- Dividend Yield
- BKU 3.06%
- IDYA N/A
- EPS Growth
- BKU 44.85
- IDYA N/A
- EPS
- BKU 3.54
- IDYA N/A
- Revenue
- BKU $1,016,093,000.00
- IDYA $214,834,000.00
- Revenue This Year
- BKU $14.68
- IDYA $90.17
- Revenue Next Year
- BKU $5.82
- IDYA $217.29
- P/E Ratio
- BKU $11.44
- IDYA N/A
- Revenue Growth
- BKU 10.45
- IDYA 5377.66
- 52 Week Low
- BKU $28.21
- IDYA $13.45
- 52 Week High
- BKU $44.45
- IDYA $33.64
- Technical
- Relative Strength Index (RSI)
- BKU 60.45
- IDYA 61.96
- Support Level
- BKU $39.51
- IDYA $28.84
- Resistance Level
- BKU $40.80
- IDYA $33.64
- Average True Range (ATR)
- BKU 1.16
- IDYA 1.48
- MACD
- BKU 0.16
- IDYA -0.12
- Stochastic Oscillator
- BKU 84.43
- IDYA 67.55
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.